The Overexpression of Myelin and Lymphocyte Protein (MAL) Downregulates MUC1 and Enhances Cisplatin Sensitivity in Non-Small Cell Lung Cancer Cells

髓鞘和淋巴细胞蛋白(MAL)的过表达可下调MUC1并增强非小细胞肺癌细胞对顺铂的敏感性

阅读:1

Abstract

The epigenetic repression of myelin and lymphocyte protein gene (MAL) and over-expression of MUC1 protein are two well-documented hallmarks of various carcinomas including lung cancer. The purpose of this work was to investigate whether ectopic expression of MAL could modify the proliferative activity of MUC1 in human lung adenocarcinoma HCC827 cells. We generated stable HCC827 cell lines, expressing GFP- or myc-MAL constructs, then, followed the expression of MUC1 by RT-qPCR and Western blot, and tested proliferation and sensitivity of those cells to cisplatin. Our results showed that ectopic expression of MAL nearly eliminated cellular levels of MUC1-C. This effect is primarily due to down-regulation of MUC1 expression, as confirmed by RT-qPCR. Additionally, lysosomal-associated degradation of MUC1 may also contribute, as observed when the cells were treated with ammonium chloride and chloroquine. The reduced quantity of MUC1-C negatively affected both cyclin D1 and c-Myc, protein levels, which are linked to cell-proliferative signals involving MUC1-C. Furthermore, expression of MAL decreased the viability of HCC827 cells, and increased their sensitivity to cisplatin. MAL and MUC1 showed an antagonistic relationship in cancer cells, and these findings provide new insights with respect to the regulation of MUC1 and a better understanding of MAL as a potential tumor suppressor.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。